Skip to main content
SpringerLink
Log in

Radiation Dosimetry

  • Chapter
Safety and efficacy of radiopharmaceuticals

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 4))

  • 95 Accesses

Abstract

For assessing the safety of a radiopharmaceutical, the radiation exposure of the patient is one of the required parameters. In general, the exposure can only be estimated by initially referring to biokinetic data from investigations in animals and subsequently using available data from man. Mean organ doses are calculated in most instances, but effective doses and local tissue doses may be of considerable importance as well. The quantities needed and methods used for dose calculations are given in this review together with some results. The relevance of these data in assessing the safety of a radiopharmaceutical will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Loevinger R, Bergman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD pamphlet No. 1, revised. New York, Society of Nuclear Medicine, 1976.

    Google Scholar 

  2. ICRP publication 26. Recommendations of the International Commission on Radiological Protection. Oxford, Pergamon Press, 1977.

    Google Scholar 

  3. Persson BRR. Effective dose equivalent concept in radiopharmaceutical dosimetry, in: E. E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166) 1981:616–624.

    Google Scholar 

  4. Roedler HD. Strahlenexposition von Patienten bei diagnostischer Anwendung von Radionukliden, in: O. Messerschmidt et al., eds. Strahlenschutz in Forschung und Praxis, Vol. XXIII, Stuttgart, Thieme Verlag 1982:79–94.

    Google Scholar 

  5. Roedler HD, Kaul A. Strahlenrisiko fûr den Patienten durch nuklearmedizinische Diagnostik, in: B. Glöbel et al., eds. Das Strahlenrisiko im Vergleich zu chemischen und biologischen Risiken, Stuttgard, Georg Thieme Verlag 1981:84–92.

    Google Scholar 

  6. Roedler HD. Accuracy of internal dose calculations with special consideration of radiopharmaceutical biokinetics, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166) 1981:1–20.

    Google Scholar 

  7. Roedler HD. Radiation dose to the patient in radionuclide studies, in: Medical Radionuclide Imaging, Vol. 1. Vienna, International Atomig Energy Agency 1981:527–542.

    Google Scholar 

  8. Roedler HD, Kaul A, Berner W, Koeppe P, Glaubitt D. Development of an extended formalism for internal dose calculation and practical application to several biologically distributed radioelements, in: Assessment of Radioactive Contamination in Man. Vienna, International Atomic Energy Agency, 1971:515–541.

    Google Scholar 

  9. Roedler HD, Strahlenbelastung durch Radiopharmaka-Entwicklung eines mathematischen Dosiskonzepts und Ergebnisse von Neuberechnungen der Energiedosis. (Thesis) Berlin, Freie Universität, 1974.

    Google Scholar 

  10. Roedler HD. Internal dosimetry of Technetium 99m labelled radiopharmaceuticals used in clinical nuclear medicine. J Beige Radiol 1977;60:463–472.

    CAS  Google Scholar 

  11. Roedler HD. Biokinetik und Dosisermi111ung, in: Medizinische Physik `79. Heidelberg, Dr. Alfred Hüthig Verlag 1979:279–284.

    Google Scholar 

  12. Roedler HD, Kragh P. Measurement of radiopharmaceutical biodistribution in patients, in: W. Bleifeld et al., eds. Proceedings of the World Congress on Medical Physics and Biomedical Engineering 1982 Hamburg, (MPBE 1982, 21.10.)

    Google Scholar 

  13. Berman M. Compartmenta1 analysis and kinetics, in: R.W. Stacy et al. eds. Computers in Biomedical Research, Vol. 2 New York, Academic Press, 1965:Chapt.7.

    Google Scholar 

  14. Kaul A, Oeff K, Roedler HD, Vogelsang T. Radiopharmaceuticals — Biokinetic data and results of recalculations of internal dose. Berlin, Informationsdienst för Nuklearmedizin, 1974: 600 pp.

    Google Scholar 

  15. Kubassi F. Tierexperimentelle Untersuchungen zur Kinetik von Tc-99m Pertechnetat und Berechnung der Strahlenexposition von Patienten (Thesis) Berlin, Freie Universität, 1975.

    Google Scholar 

  16. Berner W. Tierexperimentelle Untersuchungen zum Problem der Dekorporierung von radioaktiven Metallionen (Thesis) Berlin, Freie Universität, 1973.

    Google Scholar 

  17. MIRD Dose Estimate Report No. 5. Summary of current radiation dose estimates to humans from 1–123, 1–124, 1–125, 1–126, 1–130, 1–131 and 1–132 as sodium iodide. J Nucl Med 1 975; 16: 857.

    Google Scholar 

  18. MIRD Dose Estimate Report No. 8. Summary of current radiation dose estimates to normal humans from Tc-99m as sodium pertechnetate. J Nucl Med 1976;17:74.

    Google Scholar 

  19. Lathrop KA, Johnston RE, Blau M, Rothschild EO. Radiation dose to humans from Se-75 L-selenomethionine. MIRD pamphlet 9, J Nucl Med 1 972; 13:Suppl.6.

    Google Scholar 

  20. MIRD Dose Estimate Report No. 2. Summary of current radiation dose estimates to humans from Ga-66, G a-6 7, Ga-68 and Ga-72 citrate. J Nucl Med 1973;14:755.

    Google Scholar 

  21. ICRP Publication 30. Limits for intakes of radionuclides by workers. Oxford, Pergamon Press, 1979.

    Google Scholar 

  22. Tsui BMW, L athrop KA, Harper PV. Extrapolation from animals to the human for the retention of radiothallium in the blood, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166) 1981:283–291.

    Google Scholar 

  23. Stara JF, Nelson NS, Dellosa RJ, Bustad LK. Comparative metabolism of radionuclides in mammals: A review. Health Phys 1971;20:113–137.

    Article  PubMed  CAS  Google Scholar 

  24. Richmond CR, Furchner J E, Trafton GA, Langham WH. Comparative metabolism of radionuclides in mammals — I. Uptake and retention of orally administered Zn-65 by four mammalian species. Health Phys 1962;8:481–489.

    Article  PubMed  CAS  Google Scholar 

  25. Furchner JE, Richmond CR, Drake GA. Comparative metabolism of radionuclides in mammals — III. Retention of manganese-54 in the mouse, rat, monkey and dog. Health Phys 1966;12:1415–1423.

    Article  PubMed  CAS  Google Scholar 

  26. Furchner JE, Richmond CR, Drake GA. Comparative metabolism of radionuclides in mammals — IV. Retention of silver-110m in the mouse, rat, monkey and dog. Health Phys 1968;15:505–514.

    Article  PubMed  CAS  Google Scholar 

  27. Furchner JE, London JE, Wilson JS. Comparative metabolism of radionuclides in mammals - IX. Retention of Se-75 in the mouse, rat, monkey and dog. Health Phys 1975;29:641–648.

    Article  PubMed  CAS  Google Scholar 

  28. Furchner JE, Richmond CR, Drake GA. Comparative metabolism of radionuclides in mammals — V. Retention of Ir-192 in the mouse, rat, monkey and dog. Health Phys 1971;20:375–382.

    Article  PubMed  CAS  Google Scholar 

  29. Furchner JE, Drake GA. Comparative metabolism of radionuclides in mammals — VI. Retention of Nb-95 in the mouse, rat, monkey and dog. Health Phys 1971;21:173–180.

    Article  PubMed  CAS  Google Scholar 

  30. Furchner JE, Richmond CR, Drake GA. Comparative metabolism of radionuclides in mammals — VII. Retention of Ru-106 in the mouse, rat, monkey and dog. Health Phys 1971;21:355–365.

    Article  PubMed  CAS  Google Scholar 

  31. Thomas DM, Eberhardt LL. Extrapolation of animal radionuclide retention data to man — Use of similarity ratios, in: Biological and environmental effects of low-level radiation. Vienna, International Atomic Energy Agency 1976;235–245.

    Google Scholar 

  32. Mfee JG, Subramanian G. Interpretation of interspecies differences in the biodistribution of radioactive agents, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:292–306.

    Google Scholar 

  33. Tsui BMW, Lathrop KA, Harper PV. Extrapolation from animals to the human for the retention of radiothallium in the blood, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:283–291.

    Google Scholar 

  34. Crawford DJ, Richmond CR. Epistemo1ogica 1 considerations in the extrapolation of metabolic data from non humans to humans, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:181–197.

    Google Scholar 

  35. Lathrop KA. Collection and presentation of animal data relating to internally distributed radionuclides, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:198–203.

    Google Scholar 

  36. ICRP Publicaton 23. Report of the task group on reference man. Oxford, Pergamon Press, 1975.

    Google Scholar 

  37. Snyder WS, Ford MR, Warner GG, Watson SB. “S”, absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD pamphlet No. 11. New York, Soc of Nucl Med, 1975.

    Google Scholar 

  38. Henrichs K, Kaul A. Dosimetrie inkorporierter radioaktiver Stoffe — Altersabhängige Werte der spezifischen absorbierten Bruchteile. S-Bericht 1/1982 Berlin, Dietrich Reimer Verlag, 1982.

    Google Scholar 

  39. Henrichs K, Kaul A, Roedler HD. Estimation of age-dependent internal dose from radionuclides. Phys Med Biol 1982;27:775–784.

    Article  PubMed  CAS  Google Scholar 

  40. Roedler HD, Kaul A, Hine GO. Internal radiation dose in diagnostic nuclear medicine. Berlin, Hildegard Hoffmann Verlag, 1978.

    Google Scholar 

  41. Kaul A, Henrichs K, Roedler HD. Radionuclide biokinetics and internal dosimetry in nuclear medicine. La Ricerca Clin Lab 1980;10:62 9–660.

    Google Scholar 

  42. Kaul A, Roedler HD. Dosimetrie, in: D. Emrich, ed. Nuklearmedizin — Funktionsdiagnostik, Stuttgart, Georg Thieme Verlag 1980:107–120, 482–498.

    Google Scholar 

  43. Kaul A, Roedler HD, Hine GO. Internal absorbed dose from administered radiopharmaceuticals, in: Medical Radionuclide Imaging, Vol. II. Vienna, International Atomic Energy Agency, 1977:423–453.

    Google Scholar 

  44. ICRP Publication 17. Protection of the patient in radionuclide investigations. Oxford, Pergamon Press, 1 971.

    Google Scholar 

  45. Johansson L, Mattsson S, Nosslin B. Stråldoser fran radioaktiva ämnen i medicinskt bruk. Stockholm, Statens strålskyddsinstitut, 1981.

    Google Scholar 

  46. Smith T, Veall N, Altman DG. Dosimetry of renal radiopharmaceuticals: the importance of bladder radioactivity and a simple aid for its estimation. Brit J Radiol, 1981;54:961–965.

    Article  PubMed  CAS  Google Scholar 

  47. Jacobi W. Dosisgrenzwerte fûr berufliche Strahlenexposition — biologische Grundlagen, Festlegung, Interpretation, in: G. Möhrle et al., eds. Kurslehrbuch fûr ermächtigte Ärzte, Berlin, Hildegard Hoffmann Verlag 1980:41–58.

    Google Scholar 

  48. Johansson L. S-values for bone surfaces with a source distributed homogeneously in bone volume or with a surface deposited source, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:554–562.

    Google Scholar 

  49. Rao DV, Govelitz GF, Sastry SR. Radiotoxicity of Thallium-201 in mouse testes: Inadequacy of conventional dosimetry. J Nucl Med 1983;24:145–153.

    PubMed  CAS  Google Scholar 

  50. Reddy AR, Nagaratnam A, Kaul A, Haase V. Microdosimetry of internal emitters: A necessity? in:RJ. Cloutier et al., eds. Radiopharmaceutical Dosimetry Symposium (HEW Publication FDA 76–8044), 1976:174–185.

    Google Scholar 

  51. Hofer KG. Toxicity of radionuclides as a function of subcellular dose distribution, in: E.E. Watson et al., eds. Third International Radiopharmaceutical Dosimetry Symposium (HHS Publication FDA 81–8166), 1981:371–391.

    Google Scholar 

  52. Hofer KG. Microdosimetry of labelled cells. Paper presented at the Satellite Symposium “Labelled Cells” in Graz of the World Congress of Nuclear Medicine and Biology, 1982.

    Google Scholar 

  53. Henrichs K, Kaul A. Strahlenexposition von Kindern und Ougendlichen in der nuklearmedizinischen Diagnostik. Nucl Med 1980;19:228–231.

    CAS  Google Scholar 

  54. Roedler HD. Strahlenexposition des Patienten durch Radiopharmaka — Grenzen der Genauigkeit von Dosisberechnungen (Thesis) Berlin, Freie Universität, 1977.

    Google Scholar 

  55. Brown PH, Krishnamurthy GT, Bobba VVR, Kingston E. Radiation dose calculation for Tc-99m HIDA in health and disease. J Nucl Med 1981;22:177–183.

    PubMed  CAS  Google Scholar 

  56. Wootton R, Hammond BJ. A computer simulation study of optimal thyroid radiation protection during investigation involving the administration of radioiodine-1 abe11ed radiopharmaceuticals. Brit J Radiol 1978;51:265–272.

    Article  PubMed  CAS  Google Scholar 

  57. Herzberg B, Kaul A, Meinhold H, Roedler HD. The additional radiation dose in patients due to radioactive impurities in radionuclide generators, in: H.W. Pabst et al., eds. Nuklearmedizin-Ergebnisse in Technik, Klinik, Therapie Stuttgart, Schattauer Verlag 1974:639–642.

    Google Scholar 

  58. StH-Bericht 20/77. Ersatz von Jod-131 in der nuklearmedizinischen Diagnostik durch kurzlebige Radionuklide, insbesondere durch Jod-123. Berlin, Neuherberg, Institut für Strahlenhygiene des Bundesgesundheitsamtes, 1977.

    Google Scholar 

  59. Watson EE, Coffey OL. Radiation dosimetry of thallium-201 and its contaminants. Personal Communication, 1979.

    Google Scholar 

  60. Upton AC. Strahlenrisiko im Alltag. Spektrum der Wissenschaft, April 1982, 28–37.

    Google Scholar 

  61. Larson SM, Siegel BA, Robinson RG. Guidelines for the clinical evaluation of radiopharmaceutical drugs. J Nucl Med 1978;19:1359–1362

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Hans Detlev Roedler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Isotope-Pharmacy, The National Board of Health, Copenhagen, Denmark

    Knud Kristensen  & Elisabeth Nørbygaard  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Roedler, H.D. (1984). Radiation Dosimetry. In: Kristensen, K., Nørbygaard, E. (eds) Safety and efficacy of radiopharmaceuticals. Developments in Nuclear Medicine, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6753-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6753-3_11

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-6755-7

  • Online ISBN: 978-94-009-6753-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation